Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    [edited by] Laura K. Findeiss.
    Summary: "The diagnosis and interventional management of venous disorders is a truly core area in radiology, representing a significant percentage of the caseload of an interventional radiologist-up to 75% in some institutions. Covering common disorders such as venous ulceration and varicose veins (affecting half of adults over the age of 50) as well as such serious disorders such as thromboembolic disease, this book will present the state of the art in minimally invasive diagnosis and management of these disorders. Highly practical and authoritative, this book will open with sections on epidemiology, anatomy, and the basics of venous access and then will cover the wide range of these disorders, with practical guidelines and case examples"-- Provided by publisher.

    Contents:
    Venous Anatomy and Physiology and Epidemiology of Venous Disorders / Kathleen Hamrick and Laura K. Findeiss
    Thromboembolism / Matthew Rondina and Hanadi Farrukh
    Cerebral Venous Thrombosis / Nitish Dhingra and Kieran Murphy
    Acute Deep Venous Thrombosis : Sporadic and Compressive / Kyle Cooper, Minhaj S. Khaja, and Bill Majdalany
    Pulmonary Embolism / Akhilesh Sista and Ron Winkour
    Inferior Vena Cava Filters / Robert King and Matthew Johnson
    Chronic Venous Occlusive Disease / Deepak Sudheendra
    Peripheral Venous Insufficiency / Mary Costantino
    Vascular Access / Todd Hoffman, Laura K. Findeiss and Gordon McLennan
    Pelvic and Gonadal Venous Reflux / Douglas A. Murrey, Bill S. Majdalany, and Minhaj S.Khaja
    Portal and Mesenteric Venous Disorders / Hector Ferral and Maria del Pilar Bayona Milano
    Venous Anomalies and Syndromes : Classifications, Evaluation, and treatment / Christopher R. Bailey, Scott R. Shuldiner, and Clifford Weiss.
    Digital Access
    Provider
    Version
    Thieme MedOne Radiology
    2020
    Thieme-Connect
    2020
  • Article
    Cuna GR, Calciati A, Strada MR, Bumma C, Campio L.
    Tumori. 1978 Apr 30;64(2):143-9.
    The results of controlled clinical trial that used high doses of medroxyprogesterone acetate (MPA) in the treatment of metastatic breast cancer are reported. Two treatment reigmens were used: regimen A, 500 mg daily with a total dose of 30 g; regimen B, 1,000 mg daily with a total dose of 60 g. The overall response rates were similar, with no statistically significant difference between the two treated groups. Regimen A (lower dosage group) reached a remission rate of 44%, whereas regimen B (higher dosage group) had a remission rate of 41%. The mean duration of response was 8 months with regimen A and 9 months with regimen B. The advantages of the lower dosage regimen as opposed to the higher dosage regimen of MPA in the treatment of advanced breast cancer are discussed.
    Digital Access Access Options